Evanthia Bernitsas, MD

Department

Neurology

Position

Affiliate Professor

Articles

• Multiple Sclerosis and Related Disorders
  Williams MJ, Okai AF, Cross AH, Monson NL, Vartanian T, Thrower BW, Reder AT, English JB, Wu GF, Bernitsas E, Yap S, Ndrio J, Pei J, Mowry EM, Magrini F, Acosta J, Amezcua L, CHIMES Investigators Williams MJ, Okai AF, Cross AH, Monson NL, Vartanian T, Thrower BW, Reder AT, English JB, Wu GF, Bernitsas E, Yap S, Ndrio J, Pei J, Mowry EM, Magrini F, Acosta J, Amezcua L, CHIMES investigators. Demographics and baseline disease characteristics of Black and Hispanic patients with multiple sclerosis in the open-label, single-arm, multicenter, phase IV CHIMES trial.. Mult Scler Relat Disord.. 08/2023;2023 Aug(76):104794. PubMed PMID: 37356256.. doi: 10.1016/j.msard.2023.104794. Epub 2023 Jun 9. 2023
• Multiple Sclerosis and Related Disorders
  Grant, JG, Grant JG, Rapport LJ, Darling R, Waldron-Perrine B, Lumley MA, Whitfield KE, Bernitsas E. Grant JG, Rapport LJ, Darling R, Waldron-Perrine B, Lumley MA, Whitfield KE, Bernitsas E. Cognitive enrichment and education quality moderate cognitive dysfunction in black and white adults with multiple sclerosis. 2023 Jul 24; Mult Scler Relat Disord.. 07/2023;78:104916. PubMed PMID: 37552903. doi: 10.1016/j.msard.2023.104916.. 2023
• Appl Neuropsychol Adult
  Grant, JG, Grant JG, Rapport LJ, Darling R, Waldron-Perrine B, Bernitsas E. Grant JG, Rapport LJ, Darling R, Waldron-Perrine B, Bernitsas E. Incremental validity of brief and abbreviated neuropsychological tests toward predicting functional outcomes in multiple sclerosis. . 2023 Feb 11:1-11. doi: 10.1080/23279095.2023.2176766. Epub ahead of print.. Appl Neuropsychol Adult. 02/2023:1-11. PubMed PMID: PMID: 36773023. 2023
• Life (Basel)
  Di Stadio A, Bernitsas E, La Mantia I, Brenner MJ, Ralli M, Vaira LA, Colizza A, Cavaliere C, Laudani M, Frohman TC, De Vincentiis M, Frohman EM, Altieri M Di Stadio A^, Bernitsas E, La Mantia I, Brenner MJ, Ralli M, Vaira LA, Colizza A, Cavaliere C, Laudani M, Frohman TC, De Vincentiis M, Frohman EM, Altieri M.. Targeting Neuroinflammation to Alleviate Chronic Olfactory Dysfunction in Long COVID: A Role for Investigating Disease-Modifying Therapy (DMT)?. Life (Basel). 01/2023;13(1):226. PubMed PMID: PMID: 36676175. doi: doi: 10.3390/life13010226. 2023
• J Neurol
  Pennington, P, Weinstock-Guttman B, Kolb C, Jakimovski D, Sacca K, Benedict RHB, Eckert S, Bernitsas E, Hojnacki D, Zivadinov R. Pennington P^, Weinstock-Guttman B, Kolb C, Jakimovski D, Sacca K, Benedict RHB, Eckert S, Bernitsas E, Hojnacki D, Zivadinov R.. Communicating the relevance of neurodegeneration and brain atrophy to multiple sclerosis patients: patient, provider and researcher perspectives.. J Neurol.. 11/2022. PubMed PMID: PMID: 36376729.. doi: doi: 10.1007/s00415-022-11405-3. I contributed to data collection and review of the first and final draft. 2022
• Magn Reson Imagin
  Coffman, CH, White R, Subramanian K, Buch S, Bernitsas E, Haacke EM Coffman CH*, White R, Subramanian K, Buch S, Bernitsas E, Haacke EM. Quantitative susceptibility mapping of both ring and non-ring white matter lesions in relapsing remitting multiple sclerosis.. Magn Reson Imaging. 09/2022;91:45-51. PubMed PMID: PMID: 35605736. doi: doi: 10.1016/j.mri.2022.05.009. IMPACT FACTOR: 2.546
  91, p. 45-51 2022
• Brain Sciences
  Eslami M, Lichtman-Mikol S*, Razmjou S, Bernitsas E Eslami M, Lichtman-Mikol S*, Razmjou S, Bernitsas E. Optical Coherence Tomography in Chronic Relapsing Inflammatory Optic Neuropathy, Neuromyelitis Optica and Multiple Sclerosis: A comparative study. Brain Sciences. 08/2022;12(9):1140. doi: https://doi.org/10.3390/brainsci12091140 2022
• J Neurol Neurosurg Psychiatry
  Zivadinov R, Bergsland N, Jakimovski D, Weinstock-Guttman B, Benedict RHB, Riolo J, Silva D, Dwyer MG, DeepGRAI Registry Study group (PI: Bernitas E) Zivadinov R, Bergsland N, Jakimovski D, Weinstock-Guttman B, Benedict RHB, Riolo J, Silva D, Dwyer MG, DeepGRAI Registry Study group (PI: Bernitas E). Thalamic atrophy measured by artificial intelligence in a multicentre clinical routine real-word study is associated with disability progression. Epub ahead of print.. J Neurol Neurosurg Psychiatry. 07/2022:329333. PubMed PMID: 35902228. doi: 10.1136/jnnp-2022-329333. I contributed to data collection and revision of the final draft 2022
• JAMA Neurology
  Howard JF Jr, Nowak RJ, Wolfe GI, Freimer ML, Vu TH, Hinton JL, Benatar M, Duda PW, MacDougall JE, Farzaneh-Far R, Kaminski HJ Howard JF Jr, Nowak RJ, Wolfe GI, Freimer ML, Vu TH, Hinton JL, Benatar M, Duda PW, MacDougall JE, Farzaneh-Far R, Kaminski HJ, Zilucoplan MG Study Group (Bernitsas E, Site Co-I) . Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis: Results of a Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial.. JAMA Neurology. 05/2022;77(5):582-592. PubMed PMID: 32065623. doi: doi: 10.1001/jamaneurol.2019.5125. IMPACT FACTOR: 18.3 2022
• NeuroImage
  Buch S, Subramanian K, Jella PK, Chen Y, Wu Z, Shah K, Bernitsas E, Ge Y, Haacke EM Buch S, Subramanian K, Jella PK, Chen Y, Wu Z, Shah K, Bernitsas E, Ge Y, Haacke EM^. Revealing vascular abnormalities and measuring small vessel density in multiple sclerosis lesions using USPIO.. NeuroImage. Clinical. 01/2022;29:102525. PubMed PMID: 33338965. doi: 10.1016/j.nicl.2020.102525. IMPACT FACTOR: 4.88 2022
• Brain Sciences
  Di Stadio, A, A, Brenner, M. J, De Luca, P., Albanese, M, D'Ascanio, L, Ralli M, Roccamatisi, D, Cingolani, C, Vitelli, F, Camaioni, A., Di Girolamo, S, Bernitsas, E. Di Stadio, A, Brenner, M. J, De Luca, P., Albanese, M, D'Ascanio, L, Ralli M, Roccamatisi, D, Cingolani, C, Vitelli, F, Camaioni, A., Di Girolamo, S, Bernitsas, E. Olfactory Dysfunction, Headache, and Mental Clouding in Adults with Long-COVID-19: What Is the Link between Cognition and Olfaction? A Cross-Sectional Study.. Brain Sciences. 01/2022;12(2):154. PubMed PMID: 35203918. doi: https://doi.org/10.3390/brainsci12020154. IMPACT FACTOR: 3.33 2022
• Diagnostics (Basel)
  Haacke EM, Bernitsas E. , Subramanian K, Utriainen D, Palutla VK, Yerramsetty K, Kumar P, Sethi P, Chen Y, Latif Z, Jella P, Gharabaghi S, Wang Y, Zhang X, Comley RA, Beaver J, Luo Y. Haacke EM, Bernitsas E. , Subramanian K, Utriainen D, Palutla VK, Yerramsetty K, Kumar P, Sethi P, Chen Y, Latif Z, Jella P, Gharabaghi S, Wang Y, Zhang X, Comley RA, Beaver J, Luo Y. A Comparison of Magnetic Resonance Imaging Methods to Assess Multiple Sclerosis Lesions:Implications for Patient Characterization and Clinical Trial Design. Diagnostics (Basel). 12/2021;30(12):77. PubMed PMID: 35054244. doi: doi: 10.3390/diangostics12010077. IMPACT FACTOR: 3.992 2021
• Front Neurol
  Rube J,, Bross M~, Bernitsas C*, Hackett M, Bao F, Bernitsas E Rube J, Bross M~, Bernitsas C*, Hackett M, Bao F, Bernitsas E. Effect of Obesity on Retinal Integrity in African Americans and Caucasian Americans with Relapsing Multiple Sclerosis.. Front Neurol. 11/2021;12:743592. PubMed PMID: 34899566. doi: doi: 10.3389/fneuro.2021.743592. IMPACT FACTOR: 4. Jacob Rube and Madeline Bross contributed equally in this manuscript. 2021